圣达生物
(603079)
| 流通市值：29.00亿 | | | 总市值：29.00亿 |
| 流通股本：1.71亿 | | | 总股本：1.71亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 244,557,096.89 | 315,618,528.67 | 165,761,629.44 | 237,212,440.53 |
| 应收票据及应收账款 | 157,928,547.3 | 138,780,291.58 | 160,715,841.98 | 149,496,761.96 |
| 其中：应收票据 | 1,628,455.34 | 2,149,273.52 | 2,796,823.75 | 393,300 |
| 应收账款 | 156,300,091.96 | 136,631,018.06 | 157,919,018.23 | 149,103,461.96 |
| 应收款项融资 | 2,442,380.64 | 2,464,526.45 | 1,215,583.94 | 1,584,994.56 |
| 预付款项 | 6,313,147.65 | 3,918,515.93 | 5,521,152.21 | 4,849,145.25 |
| 其他应收款合计 | 669,346.49 | 546,255.03 | 620,497.8 | 636,552.49 |
| 存货 | 205,066,521.82 | 197,536,174.76 | 204,973,773.88 | 233,344,732.39 |
| 一年内到期的非流动资产 | 30,000,000 | 30,000,000 | 29,286,375 | - |
| 其他流动资产 | 15,393,184.05 | 19,889,037.57 | 18,773,070.82 | 21,630,374.55 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 663,384,196.72 | 708,768,058.47 | 666,883,511.03 | 648,769,629.33 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 10,700,000 | 10,700,000 | 10,700,000 | 10,700,000 |
| 固定资产 | 424,756,843.62 | 432,020,992.02 | 425,297,692.72 | 409,500,502.46 |
| 在建工程 | 394,555,153.09 | 335,957,398.45 | 329,076,820.67 | 298,303,990.45 |
| 使用权资产 | 1,252,385.02 | 1,489,747.94 | 1,783,063.93 | 927,185.33 |
| 无形资产 | 227,643,235.47 | 225,579,671.74 | 227,228,253.4 | 228,385,959.74 |
| 商誉 | 10,909,393.98 | 10,909,393.98 | 10,909,393.98 | 10,909,393.98 |
| 长期待摊费用 | 5,392,181.81 | 6,164,107.23 | 9,472,385.17 | 10,878,330.13 |
| 递延所得税资产 | 373,576.51 | 63,983.91 | 476,154.01 | 331,131.05 |
| 其他非流动资产 | 67,511,164.29 | 53,657,798.34 | 57,833,662.04 | 75,427,057.64 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,143,093,933.79 | 1,076,543,093.61 | 1,072,777,425.92 | 1,045,363,550.78 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,806,478,130.51 | 1,785,311,152.08 | 1,739,660,936.95 | 1,694,133,180.11 |
| 流动负债: | | | | |
| 短期借款 | 30,027,958.33 | 30,027,958.33 | 30,025,416.67 | 30,025,416.67 |
| 应付票据及应付账款 | 162,018,948.56 | 172,991,973.04 | 162,932,641.48 | 155,627,753.39 |
| 其中：应付票据 | 84,412,301.76 | 72,091,801.73 | 79,538,783.31 | 84,028,768.42 |
| 应付账款 | 77,606,646.8 | 100,900,171.31 | 83,393,858.17 | 71,598,984.97 |
| 合同负债 | 3,391,545.87 | 3,795,459.65 | 9,859,182.35 | 2,776,931.62 |
| 应付职工薪酬 | 12,820,277.06 | 27,994,900.03 | 22,551,195.1 | 18,611,290.55 |
| 应交税费 | 13,512,443.33 | 13,217,927.85 | 12,136,023.49 | 9,861,113.25 |
| 其他应付款合计 | 1,777,304.2 | 1,982,234.38 | 1,622,497.17 | 1,605,481.73 |
| 一年内到期的非流动负债 | 457,290.68 | 918,238.09 | - | 472,184.69 |
| 其他流动负债 | 346,404.88 | 455,092.89 | 772,257.45 | 204,898.31 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 224,352,172.91 | 251,383,784.26 | 239,899,213.71 | 219,185,070.21 |
| 非流动负债: | | | | |
| 长期借款 | 256,000,000 | 231,000,000 | 210,000,000 | 194,000,000 |
| 租赁负债 | 493,077.88 | 493,077.88 | 1,793,105.25 | 556,029.6 |
| 预计负债 | 8,100,000 | 8,100,000 | 4,050,000 | 4,050,000 |
| 递延收益 | 6,562,346.94 | 6,650,242.94 | 6,745,198.69 | 7,103,050.86 |
| 递延所得税负债 | 3,577,301.05 | 3,709,726.63 | 3,047,545.31 | 3,044,122.35 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 274,732,725.87 | 249,953,047.45 | 225,635,849.25 | 208,753,202.81 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 499,084,898.78 | 501,336,831.71 | 465,535,062.96 | 427,938,273.02 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 171,188,958 | 171,188,958 | 171,188,958 | 171,188,958 |
| 资本公积 | 669,194,129.65 | 669,194,129.65 | 669,194,129.65 | 669,194,129.65 |
| 减:库存股 | 22,080,656.17 | 22,080,656.17 | 22,080,656.17 | 22,080,656.17 |
| 盈余公积 | 58,567,589.69 | 58,567,589.69 | 57,259,119.57 | 57,259,119.57 |
| 未分配利润 | 405,671,116.21 | 383,961,631.36 | 377,524,639.3 | 372,340,446.92 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,282,541,137.38 | 1,260,831,652.53 | 1,253,086,190.35 | 1,247,901,997.97 |
| 少数股东权益 | 24,852,094.35 | 23,142,667.84 | 21,039,683.64 | 18,292,909.12 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,307,393,231.73 | 1,283,974,320.37 | 1,274,125,873.99 | 1,266,194,907.09 |
| 负债和股东权益合计 | 1,806,478,130.51 | 1,785,311,152.08 | 1,739,660,936.95 | 1,694,133,180.11 |
| 公告日期 | 2025-04-28 | 2025-04-28 | 2024-10-26 | 2024-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |